Justin Zamirowski

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Mark Heinen, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Justin Zamirowski:

Company Role Class Num Shares Value Price $ Report Date Ownership
Better Therapeutics, Inc. Chief Commercial Officer Common Stock 36,913 $6,272 $0.1699 27 May 2022 Direct
Better Therapeutics, Inc. Chief Commercial Officer Stock Option (Right to Buy) 43,626 27 May 2022 Direct

Insider Reports Filed by Justin Zamirowski

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000089924322020438-zamirowski-justin-2022-05-27 Better Therapeutics, Inc. 27 May 2022 2 +$838 4 Chief Commercial Officer 01 Jun 2022, 16:47
/report/000089924322018628-zamirowski-justin-2022-05-16 Better Therapeutics, Inc. 16 May 2022 2 +$17,618 4 Chief Commercial Officer 18 May 2022, 17:12
/report/000089924322013365-zamirowski-justin-2022-04-01 Better Therapeutics, Inc. 01 Apr 2022 1 $0 4 Chief Commercial Officer 04 Apr 2022, 16:45
/report/000089924321042241-zamirowski-justin-2021-10-28 Better Therapeutics, Inc. 28 Oct 2021 0 $0 3 Chief Commercial Officer 01 Nov 2021, 20:35